Skip to content

BIOLASE

BIOLASE is a medical device company and global market leader in the manufacturing and marketing of proprietary dental laser systems, now part of the MegaGen family.

Last updated September 15, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

BIOLASE is a medical device company and the global market leader in the manufacturing and marketing of proprietary dental laser systems. Since its founding, it has sold over 43,300 laser systems in more than 80 countries. Its product line includes the flagship all-tissue laser Waterlase iPlus Premier Edition, the Waterlase MDX, and the soft-tissue lasers Epic X and Epic Hygiene. BIOLASE is now part of the MegaGen family, under the leadership of Dr. Kwang Bum Park, CEO of MegaGen & BIOLASE. The company is based in Foothill Ranch, United States, and describes itself as the world leader in laser dentistry education and training.

History

BIOLASE is a medical device company and the global market leader in the manufacturing and marketing of proprietary dental laser systems. Since its founding, it has sold over 43,300 laser systems in more than 80 countries. BIOLASE is now part of the MegaGen family, under the leadership of Dr. Kwang Bum Park, CEO of MegaGen & BIOLASE, a partnership described as the beginning of a new era focused on bringing back the golden age of BIOLASE quality and customer care. BIOLASE was recognized as a Top Workplace in 2022 by both the Orange County Register and the Inland News Group, based on feedback collected through an employee survey administered by Energage LLC in July and August 2022.

Products and positioning

Global leader in dental lasers and laser dentistry education and training.

  • Waterlase iPlus Premier Edition

    Flagship all-tissue laser.

  • Waterlase MDX

    All-tissue laser.

  • Epic X

    Total diode solution soft-tissue laser.

  • Epic Hygiene

    Soft-tissue laser for hygienists, by hygienists.

Recent events

  • BIOLASE reports first-quarter 2020 financial results[6]

    Reported:

    BIOLASE announced its financial results for the first quarter ended March 31, 2020, reporting net revenue of $4.7 million.

  • BIOLASE appoints Michael DiTolla to its board[7]

    Reported:

    BIOLASE appointed Michael DiTolla to its board of directors, effective November 14, 2019.

Sources8 sources

Cite this profile: Cite the canonical profile. /brand-wiki/biolase-united-states · Editorial policy · How profiles are compiled